Skip to main navigation
Skip to search
Skip to main content
HSC Home
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Search by expertise, name or affiliation
Statins in the spectrum of neurologic disease
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Statins in the spectrum of neurologic disease'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Neurological Diseases
100%
Statins
100%
Neuroprotection
16%
Ischemic Stroke
16%
Neurodegenerative Diseases
16%
Pharmacodynamic Interactions
16%
Inflammation
16%
Pathogenic Mechanism
16%
Therapeutic Use
16%
Neurologic Conditions
16%
Heart Disease
16%
Hypercholesterolemia
16%
Acute Brain Injury
16%
New Evidence
16%
3-hydroxy-3-methylglutaryl-coenzyme A
16%
Central Nervous System Inflammation
16%
Cardiovascular Prevention
16%
Reductase Inhibitors
16%
Storage Diseases
16%
Secondary Prevention of Cardiovascular Diseases
16%
Neurometabolic
16%
Pharmacology, Toxicology and Pharmaceutical Science
Neurologic Disease
100%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
100%
Neuroprotection
16%
Nervous System Inflammation
16%
Inflammation
16%
Degenerative Disease
16%
Atherosclerosis
16%
Pharmacodynamics
16%
Heart Disease
16%
Brain Ischemia
16%
Oxidoreductase
16%
Brain Injury
16%
Hypercholesterolemia
16%
HMG-CoA
16%
Storage Disease
16%
Cardiovascular Disease
16%